A Systematic Approach to Design and Prepare Solid Dispersions of Poorly Water-Soluble Drug

被引:35
作者
Verma, Sanjay [1 ,2 ]
Rudraraju, Varma S. [2 ]
机构
[1] Jawaharlal Nehru Technol Univ, Ctr Pharmaceut Sci, Hyderabad 500085, Andhra Pradesh, India
[2] Aizant Drug Res Solut Pvt Ltd, Hyderabad 500014, Andhra Pradesh, India
来源
AAPS PHARMSCITECH | 2014年 / 15卷 / 03期
关键词
amorphous; cilostazol; glass transition temperature; miscibility; solid dispersions; solubility parameters; GLASS-TRANSITION TEMPERATURE; MOLECULAR MOBILITY; PHYSICAL STABILITY; AMORPHOUS PHARMACEUTICALS; THERMODYNAMIC QUANTITIES; SOLUBILITY PARAMETERS; POLYMER MISCIBILITY; MELT EXTRUSION; CILOSTAZOL; DISSOLUTION;
D O I
10.1208/s12249-014-0093-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of the present study was to define a systematic approach to design and prepare solid dispersions of poorly water-soluble drug. The systematic approach can be defined in four phases. In the first phase, glass forming ability is assessed, and in the second phase, probable excipients are screened. The screened excipients are evaluated (third phase) for glass transition temperatures (T (g)) and miscibility studies according to Florey-Huggins interaction parameter. The predicted excipients are used to prepare the solid dispersion and evaluated for T (g) and any interactions using Fourier transfer infrared studies (fourth phase), and the findings are correlated with phase three predictions. For this investigation, cilostazol (CIL) was selected as model drug, which was classified as a poor glass former. As per the physical chemical properties of CIL, ten excipients, both polymeric and non-polymeric, were selected and screened. Out of these, povidone, copovidone, hypromellose and Eudragit EPO were found theoretically miscible with CIL. After going through phase 2 to phase 4, only povidone, copovidone and hypromellose were confirmed as polymer of choice for preparing the solid dispersion of CIL with a prediction of better physical solid-state stability on the basis of good miscibility between drug and carrier.
引用
收藏
页码:641 / 657
页数:17
相关论文
共 59 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]   THE OLD PROBLEMS OF GLASS AND THE GLASS-TRANSITION, AND THE MANY NEW TWISTS [J].
ANGELL, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (15) :6675-6682
[3]   THERMODYNAMIC ASPECTS OF THE GLASS-TRANSITION IN LIQUIDS AND PLASTIC CRYSTALS [J].
ANGELL, CA .
PURE AND APPLIED CHEMISTRY, 1991, 63 (10) :1387-1392
[4]   RELAXATION IN LIQUIDS, POLYMERS AND PLASTIC CRYSTALS - STRONG FRAGILE PATTERNS AND PROBLEMS [J].
ANGELL, CA .
JOURNAL OF NON-CRYSTALLINE SOLIDS, 1991, 131 :13-31
[5]  
Chawla G., 2009, SCI PHARM, V77, P695, DOI [DOI 10.3797/scipharm.0806-09, 10.3797/scipharm.0806-09]
[6]   Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution [J].
Chokshi, RJ ;
Sandhu, HK ;
Iyer, RM ;
Shah, NH ;
Malick, AW ;
Zia, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (11) :2463-2474
[7]   The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems [J].
Craig, DQM ;
Royall, PG ;
Kett, VL ;
Hopton, ML .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 179 (02) :179-207
[8]   Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions [J].
Crowley, KJ ;
Zografi, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (10) :2150-2165
[9]   The use of thermal methods for predicting glass-former fragility [J].
Crowley, KJ ;
Zografi, G .
THERMOCHIMICA ACTA, 2001, 380 (02) :79-93
[10]  
Dawson DL, 2001, AM J CARDIOL, V87, p19D